Sales of Keytruda leads Merck to strong Q2
Sales of immunotherapy treatment, Keytruda, were up by 58% year-on-year, which led Merck to a sales increase of 12% overall compared to 2018.
Archives for July 30, 2019
Celltrion sets up Chinese JV and eyes manufacturing facility in country
Celltrion has partnered with Nan Fung Group to create Vcell Healthcare, which will manufacture and commercialize three of Celltrion’s biosimilar products in China.